<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">cardiotomsk</journal-id><journal-title-group><journal-title xml:lang="ru">Сибирский журнал клинической и экспериментальной медицины</journal-title><trans-title-group xml:lang="en"><trans-title>Siberian Journal of Clinical and Experimental Medicine</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2713-2927</issn><issn pub-type="epub">2713-265X</issn><publisher><publisher-name>TSU publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.29001/2073-8552-2026-41-3-90-102</article-id><article-id custom-type="elpub" pub-id-type="custom">cardiotomsk-3280</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>КЛИНИЧЕСКИЕ ИССЛЕДОВАНИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>CLINICAL STUDIES</subject></subj-group></article-categories><title-group><article-title>Параметры сократительного резерва левого и правого желудочков при добутаминовой стресс-эхокардиографии и трехлетняя выживаемость пациентов с ишемической болезнью сердца и систолической дисфункцией левого желудочка</article-title><trans-title-group xml:lang="en"><trans-title>Parameters of the contractile reserve of the left and right ventricles during dobutamine stress echocardiography and three-year survival in patients with coronary artery disease and left ventricular systolic dysfunction</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-8573-5695</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Рябова</surname><given-names>Т. Р.</given-names></name><name name-style="western" xml:lang="en"><surname>Ryabova</surname><given-names>T. R.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Рябова Тамара Ростиславовна - канд. мед. наук, старший научный сотрудник, лаборатория ультразвуковых и функциональных методов исследования, НИИ кардиологии Томского НИМЦ.</p><p>634012, Томск, ул. Киевская, 111а</p></bio><bio xml:lang="en"><p>Tamara R. Ryabova - Cand. Sci. (Med.), Senior Research Scientist, Department of Functional Diagnostics and Ultrasound, Cardiology Research Institute, Tomsk NRMC.</p><p>111a, Kievskaya str., Tomsk, 634012</p></bio><email xlink:type="simple">rtrtom@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3763-945X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Абраменко</surname><given-names>Е. Е.</given-names></name><name name-style="western" xml:lang="en"><surname>Abramenko</surname><given-names>E. E.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Абраменко Елена Евгеньевна - канд. мед. наук, научный сотрудник, отделение неотложной кардиологии, НИИ кардиологии Томского НИМЦ.</p><p>634012, Томск, ул. Киевская, 111а</p></bio><bio xml:lang="en"><p>Elena E. Abramenko - Cand. Sci. (Med.), Research Scientist, Department of Emergency Cardiology, Cardiology Research Institute, Tomsk NRMC.</p><p>111a, Kievskaya str., Tomsk, 634012</p></bio><email xlink:type="simple">eae@cardio-tomsk.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-0513-9012</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Соколов</surname><given-names>А. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Sokolov</surname><given-names>A. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Соколов Александр Анатольевич - д-р мед. наук, профессор, заведующий лабораторией ультразвуковых и функциональных методов исследования, НИИ кардиологии Томского НИМЦ.</p><p>634012, Томск, ул. Киевская, 111а</p></bio><bio xml:lang="en"><p>Alexander A. Sokolov - Dr. Sci. (Med.), Professor, Head of the Department of Functional and Laboratory Diagnostics, Cardiology Research Institute, Tomsk NRMC.</p><p>111a, Kievskaya str., Tomsk, 634012</p></bio><email xlink:type="simple">asa@cardio-tomsk.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-4049-8715</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Андреев</surname><given-names>С. Л.</given-names></name><name name-style="western" xml:lang="en"><surname>Andreev</surname><given-names>S. L.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Андреев Сергей Леонидович - канд. мед. наук, старший научный сотрудник, отделение сердечно-сосудистой хирургии, НИИ кардиологии Томского НИМЦ.</p><p>634012, Томск, ул. Киевская, 111а</p></bio><bio xml:lang="en"><p>Sergei L. Andreev - Cand. Sci. (Med.), Senior Research Scientist, Department of Cardiovascular Surgery, Cardiology Research Institute, Tomsk NRMC.</p><p>111a, Kievskaya str., Tomsk, 634012</p></bio><email xlink:type="simple">anselen@rambler.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-1956-0692</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Шипулин</surname><given-names>В. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Shipulin</surname><given-names>V. M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Шипулин Владимир Митрофанович - д-р мед. наук, профессор, главный научный сотрудник, НИИ кардиологии Томского НИМЦ.</p><p>634012, Томск, ул. Киевская, 111а</p></bio><bio xml:lang="en"><p>Vladimir M. Shipulin - Dr. Sci. (Med.), Professor, Chief Research Scientist, Cardiology Research Institute, Tomsk NRMC.</p><p>111a, Kievskaya str., Tomsk, 634012</p></bio><email xlink:type="simple">shipulin@cardio-tomsk.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-9887-8214</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Шипулин</surname><given-names>В. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Shipulin</surname><given-names>V. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Шипулин Владимир Владимирович - канд. мед. наук, научный сотрудник, лаборатория радионуклидных методов исследования, НИИ кардиологии Томского НИМЦ.</p><p>634012, Томск, ул. Киевская, 111а</p></bio><bio xml:lang="en"><p>Vladimir V. Shipulin - Cand. Sci. (Med.), Research Scientist, Department of Nuclear Medicine, Cardiology Research Institute, Tomsk NRMC.</p><p>111a, Kievskaya str., Tomsk, 634012</p></bio><email xlink:type="simple">shipartphoto@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-1513-8614</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Завадовский</surname><given-names>К. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Zavadovsky</surname><given-names>K. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Завадовский Константин Валерьевич - д-р мед. наук, заведующий отделом лучевой диагностики, НИИ кардиологии Томского НИМЦ.</p><p>634012, Томск, ул. Киевская, 111а</p></bio><bio xml:lang="en"><p>Konstantin V. Zavadovsky - Dr. Sci. (Med.), Head of Department of Radiation Diagnostics, Cardiology Research Institute, Tomsk NRMC.</p><p>111a, Kievskaya str., Tomsk, 634012</p></bio><email xlink:type="simple">konstz@cardio-tomsk.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Научно-исследовательский институт кардиологии, Томский национальный исследовательский медицинский центр Российской академии наук (НИИ кардиологии Томского НИМЦ)</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Cardiology Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences (Cardiology Research Institute, Tomsk NRMC)</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2026</year></pub-date><pub-date pub-type="epub"><day>02</day><month>10</month><year>2026</year></pub-date><volume>41</volume><issue>3</issue><fpage>90</fpage><lpage>102</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Рябова Т.Р., Абраменко Е.Е., Соколов А.А., Андреев С.Л., Шипулин В.М., Шипулин В.В., Завадовский К.В., 2026</copyright-statement><copyright-year>2026</copyright-year><copyright-holder xml:lang="ru">Рябова Т.Р., Абраменко Е.Е., Соколов А.А., Андреев С.Л., Шипулин В.М., Шипулин В.В., Завадовский К.В.</copyright-holder><copyright-holder xml:lang="en">Ryabova T.R., Abramenko E.E., Sokolov A.A., Andreev S.L., Shipulin V.M., Shipulin V.V., Zavadovsky K.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.sibjcem.ru/jour/article/view/3280">https://www.sibjcem.ru/jour/article/view/3280</self-uri><abstract><sec><title>Введение</title><p>Введение. Роль реваскуляризации у пациентов с выраженной ишемической дисфункцией левого желудочка (ЛЖ) остается предметом обсуждения, особенно в аспекте отбора больных и прогностической стратификации. Традиционная оценка жизнеспособности миокарда не всегда позволяет надежно прогнозировать исходы. Значение количественного анализа бивентрикулярного резерва при добутаминовой стресс-эхокардиографии (ДСЭ) изучено недостаточно.</p></sec><sec><title>Цель</title><p>Цель: оценить значимость традиционных и дополнительных показателей ДСЭ для предсказания 3-летней общей летальности у пациентов с ишемической болезнью сердца (ИБС) и выраженной систолической дисфункцией ЛЖ, направленных на выбор стратегии лечения.</p></sec><sec><title>Материал и методы</title><p>Материал и методы. В одноцентровое ретроспективное наблюдательное исследование включены 75 пациентов с ишемической систолической дисфункцией ЛЖ (возраст – 60,6 ± 7,1 года, мужчины – 70 (93,3%) человек, конечно-систолический индекс (КСИ) ЛЖ – 77,0 (69,6; 90,7) мл/м2, фракция выброса (ФВ) ЛЖ – 30,1 ± 5,6%) с доступным 3-летним витальным статусом. Всем выполнена ДСЭ с оценкой традиционных критериев жизнеспособности миокарда и сократительного резерва ЛЖ (ФВ ЛЖ, нарушения локальной сократимости (НЛС)), а также глобальной продольной деформации (GLS), насосной функции ЛЖ и продольной сократительной функции правого желудочка (ПЖ) по TAPSE и систолической пиковой скорости базального сегмента свободной стенки ПЖ (Sʹпж). Хирургическую реваскуляризацию прошли 62 (82,7%) пациента. Первичной конечной точкой была общая летальность в течение 3 лет. Прогностическую значимость показателей оценивали с помощью регрессии Кокса и анализа Каплана – Мейера.</p></sec><sec><title>Результаты</title><p>Результаты. Трехлетняя выживаемость составила 70,7%. Признаки жизнеспособного миокарда по традиционным критериям выявлены у 51 (68%) пациента, однако наличие жизнеспособного миокарда, тип ответа на стресс, прирост ФВ ЛЖ и изменение индекса НЛС не были значимо связаны с 3-летней выживаемостью. Пациенты с неблагоприятным исходом характеризовались более низкими стресс-индуцированными значениями ФВ ЛЖ, насосной функции ЛЖ (VTILVOT), худшим GLS, более выраженной дисфункцией ПЖ в покое и при ДСЭ. В однофакторных моделях Кокса значимая ассоциация с 3-летней общей летальностью выявлена для стресс-индуцированных параметров – ФВ ЛЖ, GLS, VTILVOT, УИ ЛЖ, TAPSE, Sʹпж. В двухфакторных моделях при включении показателей функции ЛЖ максимальное стресс-индуцированное значение Sʹпж сохраняло статистически значимую ассоциацию с 3-летней общей летальностью. Анализ Каплана – Мейера показал статистически значимое различие кривых выживаемости в зависимости от значений показателей Sʹпж, TAPSE и VTILVOT.</p></sec><sec><title>Заключение</title><p>Заключение. У пациентов с ИБС и выраженной систолической дисфункцией ЛЖ традиционные показатели жизнеспособности миокарда и сократительного резерва ЛЖ при ДСЭ имели ограниченную прогностическую значимость. Более тесная связь с 3-летней общей летальностью выявлена для параметров продольной сократительной функции ПЖ, прежде всего стресс-индуцированной Sʹпж и показателями насосной функции ЛЖ.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Background</title><p>Background. The role of revascularization in patients with severe ischemic left ventricular (LV) dysfunction remains a matter of debate, particularly with regard to patient selection and prognostic stratification. Conventional assessment of myocardial viability does not always reliably predict clinical outcomes. The prognostic value of quantitative assessment of biventricular reserve during dobutamine stress echocardiography (DSE) remains insufficiently studied.</p></sec><sec><title>Aim</title><p>Aim: To evaluate the prognostic value of conventional and additional DSE parameters for predicting 3-year all-cause mortality in patients with coronary artery disease (CAD) and severe LV systolic dysfunction referred for treatment strategy selection.</p></sec><sec><title>Methods</title><p>Methods. This single-center retrospective observational study included 75 patients with ischemic LV systolic dysfunction and available 3-year vital status data: mean age 60,6 ± 7,1 years, 70 (93.3%) were men, LV end-systolic volume index 77,0 (69,6; 90,7) mL/m², and LV ejection fraction (LVEF) 30,1 ± 5,6%. All patients underwent DSE with assessment of conventional markers of myocardial viability and LV contractile reserve, including LVEF and regional wall motion abnormalities (RWMA), as well as global longitudinal strain (GLS), LV pump function, and right ventricular (RV) longitudinal systolic function assessed by tricuspid annular plane systolic excursion (TAPSE) and peak systolic velocity of the basal segment of the RV free wall (RV S′). Surgical revascularization was performed in 62 (82,7%) patients. The primary endpoint was all-cause mortality within 3 years. The prognostic value of the parameters was assessed using Cox regression and Kaplan–Meier analysis.</p></sec><sec><title>Results</title><p>Results. Three-year survival was 70,7%. Myocardial viability according to conventional criteria was identified in 51 (68,0%) patients; however, the presence of viable myocardium, type of stress response, increase in LVEF, and change in wall motion score index were not significantly associated with 3-year survival. Patients with adverse outcomes had lower stress-induced LVEF, LV pump function parameters (LVOT VTI), worse GLS, and more pronounced RV dysfunction at rest and during DSE. In univariable Cox models, significant associations with 3-year all-cause mortality were found for stress-induced LVEF, GLS, LVOT VTI, LV stroke index, TAPSE, and RV S′. In limited two-variable models adjusted for LV functional parameters, the maximal stress-induced RV S′ remained significantly associated with 3-year all-cause mortality. Kaplan–Meier analysis demonstrated significant separation of survival curves according to RV S′, TAPSE, and LVOT VTI.</p></sec><sec><title>Conclusion</title><p>Conclusion. In patients with CAD and severe LV systolic dysfunction, conventional markers of myocardial viability and LV contractile reserve during DSE had limited prognostic value. A stronger association with 3-year all-cause mortality was observed for parameters of RV systolic function, particularly stress-induced RV S′, and LV pump function.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>ишемическая дисфункция левого желудочка</kwd><kwd>правый желудочек</kwd><kwd>стресс-эхокардиография</kwd><kwd>добутамин</kwd><kwd>глобальная продольная деформация левого желудочка</kwd><kwd>сердечная недостаточность</kwd><kwd>жизнеспособность миокарда</kwd><kwd>прогноз</kwd></kwd-group><kwd-group xml:lang="en"><kwd>ischemic left ventricular dysfunction</kwd><kwd>right ventricle</kwd><kwd>stress echocardiography</kwd><kwd>dobutamine</kwd><kwd>left ventricular global longitudinal strain</kwd><kwd>heart failure</kwd><kwd>myocardial viability</kwd><kwd>prognosis</kwd></kwd-group><funding-group><funding-statement xml:lang="ru">Исследование выполнено в рамках государственного задания ФНИ регистрационный № НИОКТР: 122020300044-8.</funding-statement><funding-statement xml:lang="en">The research was supported by governmental assignment, registration number NIOKTR: 122020300044-8.</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Velazquez E.J., Lee K.L., Jones R.H., et al. Coronary artery bypass surgery in patients with ischemic cardiomyopathy. N. Engl. J. Med. 2016;374:1511–1520. DOI: 10.1056/NEJMoa1602001</mixed-citation><mixed-citation xml:lang="en">Velazquez E.J., Lee K.L., Jones R.H., et al. Coronary artery bypass surgery in patients with ischemic cardiomyopathy. N. Engl. J. Med. 2016;374:1511–1520. DOI: 10.1056/NEJMoa1602001</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Perera D., Clayton T., O'Kane P.D., et al. Percutaneous revascularization for ischemic left ventricular dysfunction. N. Engl. J. Med. 2022;387(15):1351–1360. DOI: 10.1056/NEJMoa2206606</mixed-citation><mixed-citation xml:lang="en">Perera D., Clayton T., O'Kane P.D., et al. Percutaneous revascularization for ischemic left ventricular dysfunction. N. Engl. J. Med. 2022;387(15):1351–1360. DOI: 10.1056/NEJMoa2206606</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Bonow R.O., Maurer G., Lee K.L., et al. Myocardial viability and survival in ischemic left ventricular dysfunction. N. Engl. J. Med. 2011;364(17):1617–1625. DOI: 10.1056/NEJMoa1100358</mixed-citation><mixed-citation xml:lang="en">Bonow R.O., Maurer G., Lee K.L., et al. Myocardial viability and survival in ischemic left ventricular dysfunction. N. Engl. J. Med. 2011;364(17):1617–1625. DOI: 10.1056/NEJMoa1100358</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Cleland J.G., Calvert M., Freemantle N., et al. The Heart Failure Revascularisation Trial (HEART). Eur. J. Heart Fail. 2011;13:227–233. DOI: 10.1093/eurjhf/hfq230</mixed-citation><mixed-citation xml:lang="en">Cleland J.G., Calvert M., Freemantle N., et al. The Heart Failure Revascularisation Trial (HEART). Eur. J. Heart Fail. 2011;13:227–233. DOI: 10.1093/eurjhf/hfq230</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Mc Ardle B., Shukla T., Nichol G., et al. Long-term follow-up of outcomes with F-18-fluorodeoxyglucose positron emission tomography imaging-assisted management of patients with severe left ventricular dysfunction secondary to coronary disease. Circ. Cardiovasc. Imaging. 2016;9:e004331. DOI: 10.1161/CIRCIMAGING.115.004331</mixed-citation><mixed-citation xml:lang="en">Mc Ardle B., Shukla T., Nichol G., et al. Long-term follow-up of outcomes with F-18-fluorodeoxyglucose positron emission tomography imaging-assisted management of patients with severe left ventricular dysfunction secondary to coronary disease. Circ. Cardiovasc. Imaging. 2016;9:e004331. DOI: 10.1161/CIRCIMAGING.115.004331</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Erthal F., Wiefels C., Promislow S., et al. Myocardial viability: From PARR-2 to IMAGE HF – current evidence and future directions. Int. J. Cardiovasc. Sci. 2019;32(1):70–83. DOI: 10.5935/2359-4802.20180068</mixed-citation><mixed-citation xml:lang="en">Erthal F., Wiefels C., Promislow S., et al. Myocardial viability: From PARR-2 to IMAGE HF – current evidence and future directions. Int. J. Cardiovasc. Sci. 2019;32(1):70–83. DOI: 10.5935/2359-4802.20180068</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Perera D., Ryan M., Morgan H.P., et al. Viability and outcomes with revascularization or medical therapy in ischemic ventricular dysfunction: a prespecified secondary analysis of the REVIVED-BCIS2 trial. JAMA Cardiol. 2023;8(12):1154–1161. DOI: 10.1001/jamacardio.2023.3803</mixed-citation><mixed-citation xml:lang="en">Perera D., Ryan M., Morgan H.P., et al. Viability and outcomes with revascularization or medical therapy in ischemic ventricular dysfunction: a prespecified secondary analysis of the REVIVED-BCIS2 trial. JAMA Cardiol. 2023;8(12):1154–1161. DOI: 10.1001/jamacardio.2023.3803</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Kukulski T., She L., Racine N., et al. Implication of right ventricular dysfunction on long-term outcome in patients with ischemic cardiomyopathy undergoing coronary artery bypass grafting with or without surgical ventricular reconstruction. J. Thorac. Cardiovasc. Surg. 2015;149(5):1312–1321. DOI: 10.1016/j.jtcvs.2014.09.117</mixed-citation><mixed-citation xml:lang="en">Kukulski T., She L., Racine N., et al. Implication of right ventricular dysfunction on long-term outcome in patients with ischemic cardiomyopathy undergoing coronary artery bypass grafting with or without surgical ventricular reconstruction. J. Thorac. Cardiovasc. Surg. 2015;149(5):1312–1321. DOI: 10.1016/j.jtcvs.2014.09.117</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Couperus L.E., Delgado V., Palmen M., et al. Right ventricular dysfunction affects survival after surgical left ventricular restoration. J. Thorac. Cardiovasc. Surg. 2017;153(4):845–852. DOI: 10.1016/j.jtcvs.2016.09.038</mixed-citation><mixed-citation xml:lang="en">Couperus L.E., Delgado V., Palmen M., et al. Right ventricular dysfunction affects survival after surgical left ventricular restoration. J. Thorac. Cardiovasc. Surg. 2017;153(4):845–852. DOI: 10.1016/j.jtcvs.2016.09.038</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Towheed A., Sabbagh E., Gupta R., et al. Right ventricular dysfunction and short-term outcomes following left-sided valvular surgery: an echocardiographic study. J. Am. Heart Assoc. 2021;10(4):e016283. DOI: 10.1161/JAHA.120.016283</mixed-citation><mixed-citation xml:lang="en">Towheed A., Sabbagh E., Gupta R., et al. Right ventricular dysfunction and short-term outcomes following left-sided valvular surgery: an echocardiographic study. J. Am. Heart Assoc. 2021;10(4):e016283. DOI: 10.1161/JAHA.120.016283</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Шипулин В.М., Пряхин А.С., Андреев С.Л. и др. Современные клинико-фундаментальные аспекты в диагностике и лечении пациентов с ишемической кардиомиопатией (обзор). Сибирский журнал клинической и экспериментальной медицины. 2021;36(1):20–29. DOI: 10.29001/2073-8552-2021-36-1-20-29 EDN: NJRDHP</mixed-citation><mixed-citation xml:lang="en">Shipulin V.M., Pryakhin A.S., Andreev S.L., et al. Modern clinical and fundamental aspects in the diagnosis and treatment of patients with ischemic cardiomyopathy (Review). Siberian Journal of Clinical and Experimental Medicine. 2021;36(1):20–29. (In Russ.) DOI: 10.29001/2073-8552-2021-36-1-20-29 EDN: NJRDHP</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Rad A.A., Tserioti E., Magouliotis D.E., et al. Assessment of myocardial viability in ischemic cardiomyopathy with reduced left ventricular function undergoing coronary artery bypass grafting. Meta-analysis. Clin. Cardiol. 2024;47(7):e24307. DOI: 10.1002/clc.24307</mixed-citation><mixed-citation xml:lang="en">Rad A.A., Tserioti E., Magouliotis D.E., et al. Assessment of myocardial viability in ischemic cardiomyopathy with reduced left ventricular function undergoing coronary artery bypass grafting. Meta-analysis. Clin. Cardiol. 2024;47(7):e24307. DOI: 10.1002/clc.24307</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">O'Driscoll J.M., Hawkes W., Beqiri A., et al. Left ventricular assessment with artificial intelligence increases the diagnostic accuracy of stress echocardiography. Eur. Heart J. Open. 2022;2(5):oeac059. DOI: 10.1093/ehjopen/oeac059</mixed-citation><mixed-citation xml:lang="en">O'Driscoll J.M., Hawkes W., Beqiri A., et al. Left ventricular assessment with artificial intelligence increases the diagnostic accuracy of stress echocardiography. Eur. Heart J. Open. 2022;2(5):oeac059. DOI: 10.1093/ehjopen/oeac059</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Ballo H., Doghman F., Hartikainen J., et al. Speckle-tracking echocardiography for predicting improvement of myocardial contractile function after revascularization: a meta-analysis of prospective trials. Int. J. Cardiovasc. Imaging. 2023;39(3):541–553. DOI: 10.1007/s10554-022-02753-2</mixed-citation><mixed-citation xml:lang="en">Ballo H., Doghman F., Hartikainen J., et al. Speckle-tracking echocardiography for predicting improvement of myocardial contractile function after revascularization: a meta-analysis of prospective trials. Int. J. Cardiovasc. Imaging. 2023;39(3):541–553. DOI: 10.1007/s10554-022-02753-2</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Picano E., Pierard L., Peteiro J., et al. The clinical use of stress echocardiography in chronic coronary syndromes and beyond coronary artery disease: a clinical consensus statement from the European Association of Cardiovascular Imaging of the ESC. Eur. Heart J. Cardiovasc. Imaging. 2024;25(2):e65–e90. DOI: 10.1093/ehjci/jead250</mixed-citation><mixed-citation xml:lang="en">Picano E., Pierard L., Peteiro J., et al. The clinical use of stress echocardiography in chronic coronary syndromes and beyond coronary artery disease: a clinical consensus statement from the European Association of Cardiovascular Imaging of the ESC. Eur. Heart J. Cardiovasc. Imaging. 2024;25(2):e65–e90. DOI: 10.1093/ehjci/jead250</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Pellikka P.A., Arruda-Olson A., Chaudhry F.A., et al. Guidelines for performance, interpretation, and application of stress echocardiography in ischemic heart disease: from the American Society of Echocardiography. J. Am. Soc. Echocardiogr. 2020;33(1):1–41.e8. DOI: 10.1016/j.echo.2019.07.001</mixed-citation><mixed-citation xml:lang="en">Pellikka P.A., Arruda-Olson A., Chaudhry F.A., et al. Guidelines for performance, interpretation, and application of stress echocardiography in ischemic heart disease: from the American Society of Echocardiography. J. Am. Soc. Echocardiogr. 2020;33(1):1–41.e8. DOI: 10.1016/j.echo.2019.07.001</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Lancellotti P., Pellikka P.P., Budts W., et al. The clinical use of stress echocardiography in non-ischaemic heart disease: recommendations from the European Association of Cardiovascular Imaging and the American Society of Echocardiography. Eur. Heart J. Cardiovasc. Imaging. 2016;17(11):1191–1229. DOI: 10.1093/ehjci/jew190</mixed-citation><mixed-citation xml:lang="en">Lancellotti P., Pellikka P.P., Budts W., et al. The clinical use of stress echocardiography in non-ischaemic heart disease: recommendations from the European Association of Cardiovascular Imaging and the American Society of Echocardiography. Eur. Heart J. Cardiovasc. Imaging. 2016;17(11):1191–1229. DOI: 10.1093/ehjci/jew190</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Mukherjee M., Rudski L.G., Addetia K., et al. Guidelines for the echocardiographic assessment of the right heart in adults and special considerations in pulmonary hypertension: recommendations from the American Society of Echocardiography. J. Am. Soc. Echocardiogr. 2025;38(3):141–186. DOI: 10.1016/j.echo.2025.01.006</mixed-citation><mixed-citation xml:lang="en">Mukherjee M., Rudski L.G., Addetia K., et al. Guidelines for the echocardiographic assessment of the right heart in adults and special considerations in pulmonary hypertension: recommendations from the American Society of Echocardiography. J. Am. Soc. Echocardiogr. 2025;38(3):141–186. DOI: 10.1016/j.echo.2025.01.006</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Panza J.A., Chrzanowski L., Bonow R.O. Myocardial viability assessment before surgical revascularization in ischemic cardiomyopathy. J. Am. Coll. Cardiol. 2021;78(10):1068–1077. DOI: 10.1016/j.jacc.2021.07.004</mixed-citation><mixed-citation xml:lang="en">Panza J.A., Chrzanowski L., Bonow R.O. Myocardial viability assessment before surgical revascularization in ischemic cardiomyopathy. J. Am. Coll. Cardiol. 2021;78(10):1068–1077. DOI: 10.1016/j.jacc.2021.07.004</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Garatti A., Castelvecchio S., Di Mauro M., et al. Impact of right ventricular dysfunction on the outcome of heart failure patients undergoing surgical ventricular reconstruction. Eur. J. Cardiothorac. Surg. 2015;47(2):333–340. DOI: 10.1093/ejcts/ezu152</mixed-citation><mixed-citation xml:lang="en">Garatti A., Castelvecchio S., Di Mauro M., et al. Impact of right ventricular dysfunction on the outcome of heart failure patients undergoing surgical ventricular reconstruction. Eur. J. Cardiothorac. Surg. 2015;47(2):333–340. DOI: 10.1093/ejcts/ezu152</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
